COMERICA BANK - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 196 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,294,348
+43144833.3%
80,695
-16.7%
0.01%
Q2 2023$3
-99.8%
96,838
+9.7%
0.00%
-100.0%
Q4 2022$1,638
-99.9%
88,269
-13.3%
0.01%
-18.8%
Q3 2022$1,921,000
-22.1%
101,784
-6.1%
0.02%
-20.0%
Q2 2022$2,466,000
+1.5%
108,409
+2.4%
0.02%
+11.1%
Q1 2022$2,429,000
-12.8%
105,819
-1.1%
0.02%
-10.0%
Q4 2021$2,784,000
-22.6%
106,964
-3.5%
0.02%
-9.1%
Q3 2021$3,596,000
-5.7%
110,798
-1.5%
0.02%
-4.3%
Q2 2021$3,813,000
+9.0%
112,499
-3.2%
0.02%
+9.5%
Q1 2021$3,498,000
+10.2%
116,219
-2.5%
0.02%
+5.0%
Q4 2020$3,175,000
+83.2%
119,221
+0.5%
0.02%
+53.8%
Q3 2020$1,733,000
+22.0%
118,664
-0.2%
0.01%
+18.2%
Q2 2020$1,421,000
-13.1%
118,889
+5.5%
0.01%
-26.7%
Q1 2020$1,635,000
-47.5%
112,740
+2.3%
0.02%
-37.5%
Q4 2019$3,116,000
-13.1%
110,195
+0.5%
0.02%
-14.3%
Q3 2019$3,585,000
+24.8%
109,680
+0.4%
0.03%
+21.7%
Q2 2019$2,872,000
-23.7%
109,217
-3.2%
0.02%
-23.3%
Q1 2019$3,762,000
+15.0%
112,869
-4.8%
0.03%
+7.1%
Q4 2018$3,270,000
-33.2%
118,553
+5.0%
0.03%
-28.2%
Q3 2018$4,895,000
-3.4%
112,939
-4.5%
0.04%
+11.4%
Q2 2018$5,066,000
+43.9%
118,315
-2.4%
0.04%
+40.0%
Q1 2018$3,521,000
-26.8%
121,244
+1.8%
0.02%
-21.9%
Q4 2017$4,808,000
+16.2%
119,091
-0.9%
0.03%
+6.7%
Q3 2017$4,138,000
+43.8%
120,117
+0.9%
0.03%
+36.4%
Q2 2017$2,877,000
+27.4%
119,088
-3.3%
0.02%
+29.4%
Q1 2017$2,258,000
+167.2%
123,185
+138.0%
0.02%
+142.9%
Q4 2016$845,000
-19.2%
51,750
+4.8%
0.01%
-22.2%
Q3 2016$1,046,000
-27.9%
49,402
+0.3%
0.01%
-30.8%
Q2 2016$1,451,000
-24.3%
49,2510.0%0.01%
-23.5%
Q1 2016$1,918,000
-7.4%
49,251
+0.7%
0.02%
-15.0%
Q4 2015$2,071,000
+12.9%
48,923
-0.0%
0.02%
+17.6%
Q3 2015$1,834,000
-45.0%
48,925
-50.1%
0.02%
+21.4%
Q2 2015$3,332,000
+91.8%
98,072
+99.9%
0.01%
-6.7%
Q1 2015$1,737,000
-48.1%
49,070
-50.1%
0.02%
+7.1%
Q4 2014$3,350,000
+75.3%
98,336
+98.5%
0.01%
-17.6%
Q3 2014$1,911,000
-2.7%
49,537
-1.8%
0.02%0.0%
Q2 2014$1,964,000
+1.5%
50,454
-10.8%
0.02%
+13.3%
Q1 2014$1,935,000
+60.4%
56,583
-1.6%
0.02%
+66.7%
Q4 2013$1,206,000
-31.1%
57,483
-22.9%
0.01%
-25.0%
Q3 2013$1,751,000
+3.2%
74,527
+18.0%
0.01%
-14.3%
Q2 2013$1,696,00063,1340.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders